US Patent 9,192,633
United States Patent and Trademark Office
University of Iowa Research Foundation (Iowa City, IA, US)
The invention relates to a method of treating an excessive immune response including an aberrant/enhanced Th1 response by administering a helminthic parasite preparation in an amount sufficient to reduce the excessive immune response in an individual. This invention is generally directed to autoimmune diseases which involve an excessive immune response or an aberrant/enhanced Th1 response. More specifically, the present invention is directed to the treatment of Crohn's disease and ulcerative colitis, both known as IBD. While the present invention discloses specific information about the treatment of IBD, the disclosure is in no way limiting. Additionally, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis, multiple sclerosis, autoimmune thyroiditis, allergic rhinitis, colon polyps/colon cancer and asthma can be treated by the methods and compositions disclosed therein.
Creative Commons License
This work has been identified with a Creative Commons Public Domain Mark 1.0.
Weinstock, Joel V and Elliott, David E Use of parasitic biological agents for disease prevention and control. US Patent 9,192,633 filed September 19, 2008 and issued November 24, 2015. https://ir.uiowa.edu/patents/649